Highlighting the need for de-implementation - Choosing Wisely recommendations based on clinical practice guidelines by Sipila, Raija et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Highlighting the need for de-implementation - Choosing Wisely recommendations
based on clinical practice guidelines
Sipila, Raija; Mäkelä, Marjukka; Komulainen, Jorma
Published in:
B M C Health Services Research
DOI:
10.1186/s12913-019-4460-z
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Sipila, R., Mäkelä, M., & Komulainen, J. (2019). Highlighting the need for de-implementation - Choosing Wisely
recommendations based on clinical practice guidelines. B M C Health Services Research, 19, [638 ].
https://doi.org/10.1186/s12913-019-4460-z
Download date: 03. Feb. 2020
RESEARCH ARTICLE Open Access
Highlighting the need for de-
implementation – Choosing Wisely
recommendations based on clinical
practice guidelines
Raija Sipilä1* , Marjukka Mäkelä1,2 and Jorma Komulainen1
Abstract
Background: The Choosing Wisely campaign has spread to many countries. Methods for developing
recommendations are inconsistent. We describe our process of developing such recommendations from a
comprehensive national set of clinical practice guidelines (Current Care, CC) and the results of a one-year Choosing
Wisely Finland project.
Methods: Two of the authors drafted the quality and process criteria for all the Choosing Wisely Finland
recommendations. The quality criteria were relevance, feasibility, evidence-based and strength. These were
discussed in editors’ meetings and subsequently revised. Two different processes for developing recommendations
within national clinical practice guidelines were designed and piloted (processes A and B). Process A was based on
a published guideline. The recommendations are drafted by an editor and revised and approved by the guideline
development group. In process B the development of the recommendations is integrated with guideline production
or update. Choosing Wisely recommendations were then drafted for half of the published CC Guidelines. An additional
process (process C) was designed for producing independent recommendations outside a guideline.
Results: At least one Choosing Wisely recommendation could be identified from 39 out of 52 reviewed guidelines. Of
the 106 recommendations drafted, 62 (58%) were accepted for publication. The main reasons for rejection were inability
to give a strong recommendation (n= 18, 41%) and insufficient relevance (n = 14, 32%). Two thirds (n= 41, 66%) of the
published recommendations were based on high to moderate level of evidence, and 18% (n = 11) on low or very low
level of evidence, whereas for the rest, the quality of evidence was not critically appraised.
Conclusions: Choosing Wisely recommendations can be produced systematically from existing clinical practice
guidelines. The rigorous methods of evidence-based medicine ensure high-quality recommendations. We welcome
the use of our processes and methods describes in this article by other guideline-producing organizations.
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Background
De-implementation means reducing or stopping the use
of a health service or practice provided to a patient.
Reduction is appropriate in cases where interventions are
used inappropriately or have low value, e.g. interventions
that are shown to be ineffective or harmful [1]. Low-value
interventions can have an unfavorable balance between
harms and benefits or be more costly than optional inter-
ventions. De-implementation should also be considered
for interventions for which the evidence is uncertain or
lacking.
Identifying and prioritizing interventions that should
be avoided is a key challenge [2]. The Choosing Wisely
campaign was launched in 2012 to support discussions
between physicians and patients [3] about avoiding
low-value care. The campaign invited medical specialty
societies in the US to produce top 5 lists of low-value
services. Each society was free to develop lists with
their own methods using documented, publicly avail-
able processes. The criteria for topic selection were that
the procedure is used frequently, carries a significant
cost, may expose patients to harm or burden, or may
increase strain on the health care system. Each recom-
mendation should be supported by strong evidence [1].
The campaign has spread to over 20 countries [4]. In
Germany a manual and criteria have been published for
developing Choosing Wisely recommendations [5].
In Germany, several methodological challenges in pro-
ducing Choosing Wisely recommendations were identified
[6]. These include weak methodology, lack of transparency
about prioritization of topics and unrealistic expectations
for the recommendations as a solution to overuse. As one
solution to these challenges, using high-quality clinical
practice guidelines as a starting point was suggested. This
would secure systematic literature searching and appraisal,
multidisciplinarity, and consensus with independent mod-
eration. In addition, the viewpoint would change from
medical specialties to diseases.
In Finland, there is a library of 105 national evidence-
based Current Care (CC) Guidelines. Here we describe
methods for developing the Choosing Wisely Finland
recommendations from these guidelines, and for inte-
grating such recommendations back into the guidelines.
Methods
The work was inspired by international experiences,
including Choosing Wisely campaigns as well as NICE’s
Do-not-do -recommendations. We developed a method-
ology based on the scanty literature available, piloting
methods on the way. We worked in close collaboration
with guideline editors, a group of physicians with train-
ing in critical appraisal and facilitating guideline devel-
opment groups.
Setting
The Finnish Medical Society Duodecim, in co-operation
with medical specialty societies, has produced national
clinical practice guidelines (Current Care) since 1994
[7]. The guidelines cover prevention, diagnostics, med-
ical treatment, and rehabilitation of diseases. CC Guide-
lines serve as a support for treatment decisions for
healthcare professionals, with a particular emphasis on
primary care. They are available for anyone through
open access, and most of them include a patient version.
CC Guidelines are accessed over 6 million times a year.
Evidence based health care has a long history in Finland.
In addition to guidelines, systematically produced health
technology assessments (HTAs) have guided the imple-
mentation of new technologies in hospitals, including
consensus recommendations to limit the spread of low-
value technologies [8]. The Council for Choices in
Health Care in Finland produces recommendations and
defines the service basket at a societal level [9].
The production of CC Guidelines follows inter-
national standards of development [10]. The level of
evidence is graded from A to D (high to very low) [11]
based on the system launched by the Institute of
Medicine, as endorsed by the Guidelines International
Network [12]. Guideline production is publicly funded
and led by the medical profession. The editorial team
includes 11 editors representing different medical spe-
cialties. They act as project managers and evidence-
based medicine (EBM) methodologists. All guideline
development groups are multiprofessional.
The Finnish health care system is decentralized, orga-
nized by municipalities and funded by taxation, apart
from occupational health care which is funded by
employers and produced largely by private companies.
Specialized health care is provided in 20 hospital
districts, five of which have a university hospital. CC
Guidelines are well-known and widely accepted by clini-
cians and used also at organizational level [13], as all
Finnish hospital districts expect their entire staff to apply
CC Guidelines in care pathways.
Process
We decided to base our de-implementation work on the
existing comprehensive national guideline library. The
Ministry of Social Affairs and Health funded the pilot
project. The first step was to set up criteria for the rec-
ommendations. Although Choosing Wisely methods are
described by the participating societies on the Choosing
Wisely website, there were few scientific publications on
the methodology. For Choosing Wisely Finland, we
aimed to describe criteria that guaranteed transparent,
consistent, and EBM-based methodology and that was
suited for guideline producers. In line with the US
Choosing Wisely criteria relevance for patients and
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health care providers was considered important. To limit
the number of recommendations, feasibility was added
as a criterion. Transparency was primary consideration
when defining process criteria. The criteria were drafted
by the CC Editor-in-Chief (JK) and Managing Editor
(RS) and discussed in editors’ meetings. As a result,
process criteria were separated from quality criteria for
the recommendations (Table 1).
We developed a structured format for publishing [See
Additional file 1]. According to the principles of EBM,
each recommendation is accompanied by a justification,
references and, when appropriate, an evidence summary.
A short list of possible barriers for implementation is
provided when relevant.
We identified three different processes for developing
Choosing Wisely Finland recommendations (Table 2)
and discussed these with the editors. Two of these are
based on evidence gathered in a guideline production
process. In process A, the Choosing Wisely recommen-
dations were drawn from and incorporated into an
existing guideline. In process B, the development of
recommendations was integrated to the guideline devel-
opment process. The third process (Table 2, process C)
can be used when a national guideline on the subject is
not available.
In the pilot phase, five CC Guidelines were reviewed
according to process A (Table 2) and eight Choosing
Wisely recommendations were drafted. The Ministry of
Social Affairs and Health then funded a project for
developing relevant Choosing Wisely recommendations
from 50 existing CC Guidelines. In cooperation with the
Ministry, a set of recently updated guidelines were
selected from the national guideline library.
The editors were initially introduced to the Choosing
Wisely ideology in a pilot phase workshop. Subsequently,
the editors were trained to understand low-value care, and
learn the processes and quality requirements of Choosing
Wisely Finland recommendations. The training included
educational sessions, presentations as well as feedback and
problem solving.
Each editor received a set of guidelines to review. The
editors were asked to draft up to 5 recommendations
per each guideline. They identified topics and drafted
recommendations using the existing guidelines and their
evidence summaries as a basis (Table 2, process A) and
proceeded with the most relevant ones. The recommen-
dations could target treatment, diagnostic testing,
screening, rehabilitation or follow-up. Topics were often
identified and drafted in close co-operation with the
chair of the guideline development group and members
responsible for the topic. Recommendations were dis-
cussed at subsequent editors’ meetings. Before final
approval, the guideline development group members
were asked to comment on the recommendations and
consider relevance and other criteria. Consensus was
reached by discussions. The Managing Editor led the
project, tutored other editors and provided detailed indi-
vidual feedback.
Results
Altogether 52 guidelines were reviewed during the
project. In 13 (25%) guidelines, no recommendations
fulfilling the Choosing Wisely criteria were identified.
For the remaining 39 guidelines, 106 recommendations
were drafted, and 62 (58%) of these were accepted for
publication [see Additional file 2]. Because relevance was
considered to be insufficient, recommendations were
rejected in 14 cases. In another 8 cases the underlying
evidence was judged to be too weak for a strong recom-
mendation according to GRADE criteria. In 18 cases a
strong recommendation against an intervention was not
possible due to the complexity of the issue in the Finnish
health care setting. In four cases the evidence was out-
dated, and a new literature search and review would
have been required.
A third of the published recommendations were re-
lated to pharmacotherapy (n = 21), whereas a quarter
dealt with diagnostics (n = 15). None were related to psy-
chosocial treatments or rehabilitation. Twenty-two of
the 62 recommendations were supported by high-level
of evidence, 19 by moderate level, 10 by low level and 1
by very low level of evidence. In 10 cases an evidence
summary was considered unnecessary, typically because
they dealt with overdiagnosis, overtreatment or well-
known, and potentially serious adverse events. A typical
justification for a Choosing Wisely recommendation was
Table 1 Criteria for the Choosing Wisely recommendations
Quality criteria
Relevance: The recommendation should target an intervention that
• can cause significant harm to patients or the health care system or
• is ineffective but widely used or
• has a notable economic impact
Feasible: Possibility to have an impact on clinical practice
Evidence-based: The recommendation is based on critically appraised
literature, preferably presented in evidence summaries
Strength: A possibility to give a strong recommendation* (GRADE
criterion) [14]
Process criteria
The reasons for acceptance or rejection are documented
The authors of the recommendation do not have significant conflicts
of interest
The recommendations are published in a consistent format including
a short justification
The Finnish Medical Society has the final decision on publishing
*A strong recommendation can in certain cases be given independent of the
level of evidence
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an unfavorable balance between benefits and harms or
ineffectiveness of the intervention (Table 3).
Discussion
In contrast to most Choosing Wisely campaigns that start
by identifying isolated" Things Providers and Patients
Should Question", we utilized existing clinical practice
guidelines. We also developed and applied systematic evi-
dence-based methods to secure the trustworthiness of the
recommendations. Methodological requirements in the
US Choosing Wisely campaign are rather loose (e.g. being
evidence-based) and the reported methodologies vary
from Delphi method to adopting other medical societies’
recommendations [1].
A major strength of our work is that the recommenda-
tions are developed systematically and transparently,
using EBM methodology. According to one report, only
32% of Choosing Wisely recommendations were judged
Table 2 The processes for developing Choosing Wisely recommendations in Finland
Process A. Based on a published guideline Process B. Integrated with
guideline production or update
Process C. Independent recommendation
Step 1. Topic
proposal
An editor reviews the guideline for
possible recommendations
A proposal from a guideline
development group member,
discussed in the group
A proposal from a medical specialty society,
other organization or individual
Step 2.
Recommendation
draft with
justification
The editor based on the guideline and
evidence summaries
Group member based on
literature search and critical
appraisal
An editor based on literature search and
critical appraisal
Step 3. Review and
revision
Revisions based on comments from the
chair and relevant guideline development
group members.
Final approval by the Editor-in-Chief
(documented).
Informing the group and possible
comments.
Comments from the group.
External review (of the guideline
draft).
Possible revisions.
Final approval by the Editor-in-
Chief (documented).
Comments from 1 to 2 topic experts, possible
revisions.
External review (of the recommendation): e-
questionnaire, quality criteria assessed with a
Likert scale from 1 to 5.
Possible revisions.
Final approval by the Editor-in-Chief
(documented).
Step 4. Publishing Incorporating the recommendations into
the guideline.
Technical editing and publishing.
Incorporating the
recommendations into the
guideline.
Technical editing and publishing.
Technical editing and publishing.
Table 3 Justification categories for Choosing Wisely recommendations with examples. The categories are modified from Choosing
Wisely principles and the GRADE criteria
Category Number of
recommendations*
Guideline: Choosing Wisely recommendation Justification (level of evidence)
Unfavorable
balance between
benefits and
harms
27 Urinary tract infection: Do not treat asymptomatic
bacteriuria in the elderly, because it does not
decrease incontinence, urinary tract infections or
mortality.
Eradication of bacteriuria does not decrease
incontinence, urinary tract infections or mortality.
Antibiotics have side effects and increase
antimicrobial resistance. (A)
Ineffective
treatment or
insensitive
diagnostic test
22 Tendon disorders of the shoulder: Do not use
ultrasound to treat tendon disorders of the shoulder.
Ultrasound therapy is not more effective than
placebo (pain, function). (A)
Unnecessary
intervention
11 Stable Coronary Artery Disease: Do not do an
exercise test for a patient with chest pain and low
probability of coronary artery disease.
In this patient group the likelihood of a false positive
result is high. (no evidence summary) [22, 23]
Alternative
treatment
options more
effective
8 Acute otitis media: Do not routinely treat
tympanostomy tube otorrhea with oral antibiotics.
Topical antibiotics are more effective than oral
antibiotics in the treatment of tympanostomy tube
otorrhea. Oral antibiotics have more side effects and
increase antimicrobial resistance. (B)
Unfavorable
balance between
benefits and
costs
3 Age-related macular degeneration: Avoid
ranibizumab and aflibercept as first line treatments
for age related macular degeneration due to high
costs.
Comparable effectiveness but higher costs than
other treatment options. (B)
No evidence for
effectiveness
2 Glaucoma: Do not routinely measure diurnal
fluctuations in intraocular pressure following
monitoring progression of glaucoma.
The benefit is uncertain. There is little research and
its quality is low. (D)
*A recommendation could be classified into several categories
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sufficiently trustworthy [14]. Admon et al. extracted all
320 recommendations published by the Society of
Hospital Medicine and found that a majority (70%) were
referring to guidelines of variable quality while only one in
five was linked to primary research [15].
According to GRADE, a strong recommendation
should usually be based on at least moderate confidence
in effect estimates [16]. Of our Choosing Wisely recom-
mendations, 66% were based on a high to moderate level
of evidence. For 16% the quality of the evidence was not
formally assessed in the guideline. One study found that
under 10% of the US Choosing Wisely recommendations
were based on low-quality evidence [15], but in the pri-
mary care context, the majority of recommendations
were self-evident, e.g. based on “consensus or disease-
oriented evidence” [17]. We have not formally compared
our Choosing Wisely recommendations to the US rec-
ommendations but made some interesting observations.
It seems that our criteria result in fewer recommenda-
tions per topic or disease. According to our results, the
main reasons for rejecting a recommendation were a
lack of relevance and complexity of the issue. Some
recommendations may be acceptable in one setting but
not in another one. For example, for type 2 diabetes, the
US library has a recommendation to “Avoid routine
multiple daily self-glucose monitoring in adults with
stable type 2 diabetes on agents that do not cause
hypoglycemia.” [1] We suggested a similar recommenda-
tion, but our guideline development group assessed the
issue to be too complex as there are some patient groups
that may benefit from such monitoring. The guideline
development group pointed out that municipalities
already have restricted the distribution of test strips.
Our method has several other strengths. The criteria
are clearly described, making the process transparent.
Each recommendation also includes a justification and,
if appropriate, an evidence summary. The justification
provides detailed reasoning for the reader. This is
especially important if the evidence is of low quality or
lacking. The reader thus gets an opportunity to make
informed decisions to avoid low-value care and receives
tools for shared decision-making. We also argue that the
process changes the viewpoint from specialty-oriented to
more disease-oriented when a guideline development
group formulates recommendations. Furthermore, a
multiprofessional group probably evaluates the relevance
of a recommendation more widely than a group from
one specialist society.
One limitation of our process is that the quality
criteria are not formally assessed when producing rec-
ommendations from guidelines with processes A and B.
The recommendations are, however, based on evidence
gathered and assessed by a guideline development group
during the guideline process. A more formal assessment
would naturally increase the transparency of the process.
A more extensive formal review is planned for recom-
mendations that are not based on a guideline (Table 2,
process C). Both quality and process criteria are checked
by the Editor-in-Chief before final approval. At this
point, in particular the level and quality of evidence as
well as the possibility to give a strong recommendation
are ascertained.
Another limitation is that our guideline development
groups do not include patients. We plan to involve lay
representatives in guideline production, including the
steps for Choosing Wisely Finland recommendations. This
may increase the relevance of the recommendations.
Forty-four of the draft recommendations were not
published. The main reason for this was that we were
unable to give a strong recommendation against an
intervention due to complexity of the issue at hand. This
underlines the need to discuss evidence and reach a con-
sensus to avoid oversimplification and conflicts. We did
not use a full GRADE process, where the importance of
each outcome is weighed and tabulated. This would
likely be useful when guidelines are updated and new
Choosing Wisely recommendations are drafted.
Conflict of interest declarations are gathered from all
authors during CC Guideline production or updates
(Process B, Table 2). However, for the other two pro-
cesses, formal updated declarations are not requested as
of yet.
Awareness is the first step to change. To raise aware-
ness of our recommendations we use our website, social
media, press releases and sessions at continuing medical
education events. Selected recommendations are also
published in the scientific journal of the Finnish Medical
Society Duodecim. Choosing Wisely campaigns aim to
facilitate discussions between physicians and patients.
The US campaign includes posters and videos for the
public. Relevant Choosing Wisely recommendations are
incorporated into the patient versions of CC Guidelines.
To produce more extensive material to the public, how-
ever, we would need more resources and co-operation
with patient organizations. So far, we have not studied
changes in awareness or the actual impact of our recom-
mendations. In the US, change in awareness was negli-
gible during the campaign in 2014–2017 [18]. Some
small changes in intervention prevalence have been
detected, but the clinical impact of the decrease has
remained questionable [19].
Guideline implementation research shows that dissemin-
ation is not enough to change practices; active interventions
are needed. There is little research on de-implementation
and most behavioral theories do not differentiate between
trying to increase and decrease the frequency of a behavior
[20]. Typical major barriers to avoiding low-value care in-
clude malpractice concerns, time pressures in the clinical
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encounter, patient demand, and physicians’ need for more
information to reduce uncertainty [18, 21]. Choosing
Wisely recommendations are one tool to facilitate change,
but other interventions would be needed to overcome
barriers.
Conclusions
We have shown that it is feasible to produce Choosing
Wisely recommendations systematically from existing
evidence-based clinical practice guidelines. A parallel
production of guidelines and Choosing Wisely recom-
mendations has obvious benefits: duplicate work is
avoided and rigorous EBM methods and processes
ensure high quality recommendations. Other guideline
producers are welcome to make use of our processes
and methods.
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